After Nvidia CEO's quantum computing forecast, strategist says 'good luck' to investorsByAndy MillsPublishedJanuary 8, 2025
Donald Trump's inaugural fund raised a record amount of cash. Here are the major donorsByWilliam GavinUpdatedJanuary 14, 2025
Eli Lilly is partnering with Ro to make it easier than ever to get ZepboundByBruce GilPublishedDecember 11, 2024
Amgen says its Ozempic competitor helped patients lose 20% of their weight. Wall Street isn't impressedByBruce GilUpdatedNovember 26, 2024
Walmart just became the biggest company to roll back its DEI initiativesByWilliam GavinUpdatedNovember 26, 2024
Ozempic 2.0, the Oura ring's new trick, and RFK Jr. vs. vaccines: Pharma news roundupByBruce GilPublishedNovember 22, 2024
Pfizer, Moderna, and other vaccine stocks are falling as Trump taps anti-vaxxer RFK Jr. for health secretaryByWilliam GavinPublishedNovember 15, 2024
How an election win for Donald Trump or Kamala Harris will affect stocksByWilliam GavinPublishedNovember 4, 2024
Eli Lilly's Zepbound sales, Pfizer wants in on weight loss drugs, AbbVie's big deal: Pharma news round upByBruce GilPublishedNovember 1, 2024
Amazon, Apple, Google, Meta, and Microsoft earnings, a big jobs report: What to watch in the markets this weekByVinamrata ChaturvediPublishedOctober 27, 2024
Donald Trump's likely choices to run the SEC include a Robinhood exec and 'CryptoDad'ByWilliam GavinPublishedOctober 15, 2024
Ozempic and prescription weight loss drugs: How they work, what they cost, side effects, and everything to knowByBruce GilPublishedOctober 9, 2024
